Ionis to hold third quarter 2024 financial results webcast

Ionis Pharmaceuticals (Nasdaq: IONS) has announced a webcast to discuss its third quarter 2024 financial results.

Rhea-AI Summary

Ionis Pharmaceuticals (Nasdaq: IONS) has announced a webcast to discuss its third quarter 2024 financial results. The event is scheduled for Wednesday, November 6th at 11:30 a.m. Eastern Time. Investors and interested parties can access the webcast through the company's investor relations website, with a replay available for a time after the event.

Argus Publication session

-0.67% session move Open Argus

Details

News Market Reaction – IONS

In the trading session that priced this news, IONS declined 0.67%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Webcast scheduled for Wednesday, November 6 at 11:30 a.m. Eastern Time

CARLSBAD, Calif., Oct. 23, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, November 6^th at 11:30 a.m. Eastern Time to discuss its third quarter 2024 financial results.

The webcast may be accessed at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address. 

About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn.

Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – IR@ionis.com – 760-603-2331 

Ionis Pharmaceuticals Media Contact:
Hayley Soffer – media@ionis.com – 760-603-4679

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-hold-third-quarter-2024-financial-results-webcast-302283732.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Ionis Pharmaceuticals (IONS) release Q3 2024 earnings?

Ionis Pharmaceuticals will discuss its Q3 2024 financial results on Wednesday, November 6th at 11:30 a.m. Eastern Time via a webcast.

How can I access Ionis Pharmaceuticals (IONS) Q3 2024 earnings webcast?

The webcast can be accessed through Ionis' investor relations website at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available at the same address for a time.

Will there be a replay available for Ionis (IONS) Q3 2024 earnings call?

Yes, a replay of the Q3 2024 earnings webcast will be available for a time at the same website address where the live webcast is hosted.